Company Performance - Sensus Healthcare, Inc. closed at $4.64, reflecting a -2.11% change from the previous day, underperforming the S&P 500's daily loss of 0.11% [1] - Over the past month, shares have appreciated by 0.42%, lagging behind the Medical sector's gain of 1.66% and the S&P 500's gain of 5.17% [1] Upcoming Earnings - Analysts expect Sensus Healthcare, Inc. to report earnings of $0.01 per share, indicating a year-over-year decline of 90% [2] - The consensus estimate for revenue is $8.8 million, representing a 4.76% decline compared to the same quarter last year [2] Annual Estimates - For the annual period, the Zacks Consensus Estimates predict earnings of $0.11 per share and revenue of $41.95 million, reflecting shifts of -73.17% and +0.34% respectively from the previous year [3] - Recent changes in analyst estimates suggest evolving short-term business trends, with positive revisions indicating analyst optimism regarding business and profitability [3] Zacks Rank and Valuation - Sensus Healthcare, Inc. currently holds a Zacks Rank of 5 (Strong Sell), with the Zacks Consensus EPS estimate remaining steady over the past month [5] - The company is trading at a Forward P/E ratio of 43.09, which is a premium compared to the industry average Forward P/E of 27.15 [6] Industry Context - The Medical - Instruments industry, part of the Medical sector, has a Zacks Industry Rank of 181, placing it in the bottom 27% of over 250 industries [6] - The Zacks Industry Rank assesses the strength of industry groups based on the average Zacks Rank of individual stocks, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]
Sensus Healthcare, Inc. (SRTS) Declines More Than Market: Some Information for Investors